Studies » Ongoing Studies Colorectale Carcinom

Ongoing Studies Colorectal
Carcinom

Studies
No.		 Studies Title Studies Design Coordinating Investigator Random sample Starting of recruitment
C05 Petacc 8 PETACC 8: Adjuvant treatment of fully resected stage III colon cancer with Folfox-4 plus Cetuximab versus Folfox-4 European Open randomized, controlled, multinational/ multicenter Phase III study
Study C05
Study C05
 Tschmelitsch, J
Thaler, J
Total: 667 pat./year; planned in Austria 75 pat./year (duration 3 years) 1st quarter 2006
C06 QUASAR 2 - Multicentre international study of capecitabine ± bevacizumab as adjuvant treatment of colon cancer


 Stúdy C06
Study C06
Tschmelitsch, J
Thaler, J 		2240 pat. international, 200 pat. in Austria 01/2007